Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Maryland, Baltimore

About this trial

The purpose of this research study is to test a new process for diagnosing breast cancer by examining changes to your DNA that can be detected from a blood test. The information we learn by doing this study could potentially help people in the future.

Participants in this study will have blood samples collected, have their medical records reviewed by study personnel and fill out questionnaires at different time points during the study. Blood sample collection will occur during normal routine clinic visits. Participation in this study will last approximately 5 years.

Eligibility criteria

Qualifiers

18 years old or older

Patient of UMMS

Willing and able to consent to study procedures listed in the protocol

Ability to speak and understand English

Disqualifiers

Younger than 18 years old

Patient not cared for at UMMS

Unable to consent to study procedures listed in the protocol

Unable to speak or understand English

Trial design

Treatments tested in this trial

  • Epigenetic Assay

Treatment groups

450 Participants
are divided into 3 treatment groups

Sponsors and collaborators

University of Maryland, Baltimore

Lead sponsor

EPOCH Epigenetics, Inc

Collaborator